Showing results (11-20 of 25,160) with videos related to
Sort By:
Pageof 2,516
Oncotarget|October 9, 2010
Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistanceLei Shi, Siqing Wang, Maurizio Zangari, et al.Oncotarget|November 30, 2010
CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cellsJuan R Cubillos-Ruiz, Diana Martinez, Uciane K Scarlett, et al.Oncotarget|March 8, 2011
The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic targetGabriel J Villares, Maya Zigler, Menashe Bar-EliOncotarget|March 8, 2011
miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinomaNijiro Nohata, Yaeko Sone, Toyoyuki Hanazawa, et al.Oncotarget|March 8, 2011
FAM190A rearrangements provide a multitude of individualized tumor signatures and neo-antigens in cancerFrancesca Scrimieri, Eric S Calhoun, Kalpesh Patel, et al.Oncotarget|August 12, 2010
Overexpression of POLQ confers a poor prognosis in early breast cancer patientsGeoff S Higgins, Adrian L Harris, Remko Prevo, et al.Oncotarget|October 16, 2010
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cellsEmily J Noonan, Robert F Place, Shashwati Basak, et al.Oncotarget|February 9, 2011
Src activates Abl to augment Robo1 expression in order to promote tumor cell migrationP Raaj Khusial, Bhaskar Vadla, Harini Krishnan, et al.Oncotarget|March 30, 2011
Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomibNickolay Neznanov, Andrei P Komarov, Lubov Neznanova, et al.Oncotarget|April 2, 2011
miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumorsErdogan Pekcan Erkan, Xandra O Breakefield, Okay SaydamPageof 2,516